OPKO Health, Inc. (TLV:OPK)
447.20
-6.40 (-1.41%)
Jul 31, 2025, 3:45 PM IDT
OPKO Health Revenue
OPKO Health had revenue of $149.95M USD in the quarter ending March 31, 2025, a decrease of -13.66%. This brings the company's revenue in the last twelve months to $689.41M, down -13.78% year-over-year. In the year 2024, OPKO Health had annual revenue of $713.14M, down -17.41%.
Revenue (ttm)
$689.41M
Revenue Growth
-13.78%
P/S Ratio
1.40
Revenue / Employee
$230.03K
Employees
2,997
Market Cap
3.59B ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 713.14M | -150.35M | -17.41% |
Dec 31, 2023 | 863.50M | -140.70M | -14.01% |
Dec 31, 2022 | 1.00B | -770.52M | -43.42% |
Dec 31, 2021 | 1.77B | 339.31M | 23.64% |
Dec 31, 2020 | 1.44B | 533.48M | 59.15% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 61.87B |
Danel (Adir Yeoshua) | 2.81B |
Kamada | 622.70M |
Bait Bakfar | 104.50M |
SofWave Medical | 235.09M |
BrainsWay | 161.81M |
Novolog (Pharm-Up 1966) | 2.07B |
Ilex Medical | 922.08M |
OPKO Health News
- 4 weeks ago - NextPlat Issues Interim CEO Update Shareholder Letter - PRNewsWire
- 5 weeks ago - OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium - GlobeNewsWire
- 7 weeks ago - OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy - Seeking Alpha
- 2 months ago - OPKO Health to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Opko health outlines $675M-$685M revenue guidance for 2025 amid strategic initiatives - Seeking Alpha
- 3 months ago - OPKO Health, Inc. (OPK) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - OPKO Health Q1 2025 Earnings Preview - Seeking Alpha
- 3 months ago - This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Benzinga